EP3574897
LYFJAFRÆÐILEG FORÐALYFSBLANDA SEM INNIHELDUR FJÖLLIÐU PRÓTEIN SMÁAGNIR TIL NOTKUNAR Í AUGNHLAUPI TIL MEÐFERÐAR VIÐ ÆÐARÖSKUN Í AUGUM.
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.11.2012EP published:
5.1.2022EP application number:
19180351.9
EP translation filed:
25.3.2022Grant published:
15.5.2022EPO information:
European Patent Register
Max expiry date:
17.11.2032Expiry date:
17.11.2026Next due date:
30.11.2026
Title in English:
EXTENDED RELEASE FORMULATION COMPRISING POLYMER PROTEIN MICROPARTICLES FOR USE IN THE VITREOUS OF THE EYE FOR TREATING VASCULAR EYE DISORDERSLanguage of the patent:
English
Timeline
Today
18.11.2012EP application
5.1.2022EP Publication
25.3.2022Translation submitted
15.5.2022Registration published
17.11.2026Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
CHEN, HunterAddress:
Tarrytown, NY 10591, US
Name:
WALSH, ScottAddress:
Tarrytown, NY 10591, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201161561525 PDate:
18.11.2011Country:
US
Classification
Categories:
A61K 9/50, A61K 38/17, A61K 39/00, A61P 27/02, A61K 9/16
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 20.10.2022
Expires: 17.11.2023
Payer: Patice ehf.
Number: 11
Paid: 20.10.2022
Expires: 17.11.2023
Payer: Patice ehf.
Number: 12
Paid: 6.11.2023
Expires: 17.11.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 25.10.2024
Expires: 17.11.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 11.11.2025
Expires: 17.11.2026
Payer: Árnason Faktor ehf.